Clinical Efficacy Evaluation of Continuous Renal Replacement Therapy in Neonates with Multiple Organ Dysfunction Syndrome: a Two-Centered Retrospective Study

Xiaoyun Chu,Jinglin Xu,Yifan Sun,Xiaohui Gong,Dongmei Chen,Cheng Cai
DOI: https://doi.org/10.21203/rs.3.rs-5336945/v1
2024-01-01
Abstract:Purpose: To investigate the effectiveness and safety of continuous renal replacement therapies (CRRT) for the treatment of neonatal multiple organ dysfunction syndrome (MODS). Methods: We retrospectively analyzed clinical data of 60 neonateswith MODS treated with CRRT in the neonatal intensive care unit (NICU) at two tertiary hospitals from January 2015 to May 2022. Hemodynamic parameters, liver and renal function, electrolytes, acid-base balance and routine blood indicators were recorded before CRRT, 12, 24h after CRRT initiation, and at the end of CRRT, respectively. Results: (1) A total of 60 MODS neonates were included, of which gestational age was 38.7 (37.0, 39.8) weeks, birth weight was 3125.0 (2737.5, 3457.5) g, number of organs involved was 5.0 (4.0, 6.0). (2)Compared to pre-CRRT, the mean arterial pressure (MAP), blood lactate, urine output, serum creatinine, serum urea nitrogen, serum calcium, serum potassium, and leukocyte count were significantly improved at 12 h of CRRT. pH increased significantly at 24 h of CRRT, and the vasoactive inotropic score (VIS) decreased significantly at the end of CRRT. Complications of CRRT included platelet depression (58.3%), bleeding or thrombosis (18.3%), hypotension (18.3%), electrolyte disturbances (18.3%), and line blockage (16.7%). In total, 37 out of 60 neonates survived during hospitalization, with an overall survival rate of 61.7%. Conclusions: Mortality in critically ill neonates with MODS requiring CRRT remains high. CRRT may be a safe and effective adjunctive therapy for critically ill neonates with MODS.
What problem does this paper attempt to address?